NYSE:ACB - Aurora Cannabis Stock Price, News & Analysis

$5.64
-0.15 (-2.59 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$5.64
Now: $5.64
$5.87
50-Day Range
$5.6570
MA: $6.57
$7.56
52-Week Range
$4.58
Now: $5.64
$12.52
Volume9.18 million shs
Average Volume13.62 million shs
Market Capitalization$5.74 billion
P/E Ratio47.00
Dividend YieldN/A
Beta2.44
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone1-855-279-4652

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$43.49 million
Cash Flow$0.1127 per share
Book Value$2.17 per share

Profitability

Net Income$56.66 million
Net Margins-122.65%

Miscellaneous

Employees967
Outstanding Shares1,017,440,000
Market Cap$5.74 billion
Next Earnings Date9/24/2019 (Estimated)
OptionableOptionable

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.


Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release their next quarterly earnings announcement on Tuesday, September 24th 2019. View Earnings Estimates for Aurora Cannabis.

What guidance has Aurora Cannabis issued on next quarter's earnings?

Aurora Cannabis updated its fourth quarter 2019 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $76-81.32 million.

What price target have analysts set for ACB?

10 Wall Street analysts have issued 12 month price targets for Aurora Cannabis' stock. Their predictions range from $7.00 to $9.50. On average, they anticipate Aurora Cannabis' stock price to reach $8.3740 in the next twelve months. This suggests a possible upside of 48.5% from the stock's current price. View Analyst Price Targets for Aurora Cannabis.

What is the consensus analysts' recommendation for Aurora Cannabis?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aurora Cannabis.

Has Aurora Cannabis been receiving favorable news coverage?

Press coverage about ACB stock has been trending positive this week, according to InfoTrie. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aurora Cannabis earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term. View News Stories for Aurora Cannabis.

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), HEXO (HEXO), Tilray (TLRY), NVIDIA (NVDA), KushCo (KSHB), Micron Technology (MU), Alibaba Group (BABA) and Advanced Micro Devices (AMD).

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the folowing people:
  • Mr. Michael Singer, Exec. Chairman (Age 54)
  • Mr. Terry Booth, Founder, CEO & Director (Age 54)
  • Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.15%), ETF Managers Group LLC (1.11%), Morgan Stanley (0.79%), TD Asset Management Inc. (0.32%), Sumitomo Mitsui Trust Holdings Inc. (0.27%) and JPMorgan Chase & Co. (0.26%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Connor Clark & Lunn Investment Management Ltd., AMP Capital Investors Ltd, Cubist Systematic Strategies LLC, Signition LP, HBK Sorce Advisory LLC, Texas Yale Capital Corp. and Intercontinental Wealth Advisors LLC.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, JPMorgan Chase & Co., Renaissance Technologies LLC, Vanguard Group Inc., Janus Henderson Group PLC, Janus Henderson Group PLC, Sumitomo Mitsui Trust Holdings Inc. and Swiss National Bank.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $5.64.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of $5.74 billion and generates $43.49 million in revenue each year. The company earns $56.66 million in net income (profit) each year or $0.12 on an earnings per share basis. Aurora Cannabis employs 967 workers across the globe.View Additional Information About Aurora Cannabis.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is http://auroramj.com/.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]


MarketBeat Community Rating for Aurora Cannabis (NYSE ACB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  260 (Vote Underperform)
Total Votes:  465
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel